Microfluidic chip-based, universal coagulation assay
AssigneePerosphere Technologies Inc.
InventorsSasha Bakhru, Bryan Laulicht, Stefan Zappe, Solomon Steiner
Life of this patent
Estimating the term…
Loading patent…
AssigneePerosphere Technologies Inc.
InventorsSasha Bakhru, Bryan Laulicht, Stefan Zappe, Solomon Steiner
Estimating the term…
A microfluidic, chip-based assay device has been developed for measuring physical properties of an analyte (particularly, whole blood or whole blood derivatives). The technologies can be applied to measure clotting times of whole blood or blood derivatives, determine the effects of anticoagulant drugs on the kinetics of clotting/coagulation, as well as evaluate the effect of anticoagulant reversal agents. These technologies can additionally be used to optimize the dosage of anticoagulation drugs and/or their reversal agents. The assay is independent of the presence of anticoagulant; clotting is activated by exposure of the blood sample in the device to a glass (or other negatively charged material such as oxidized silicon) surface, which activates the intrinsic pathway and can be further hastened by the application of shear flow across the activating materials surface. The absence of chemical activating agents and highly controlled and reproducible micro-environment yields a point of care universal clotting assay.
A test microchip for measuring clotting in a blood or plasma sample, the test microchip comprising,
A microassay system for measuring clotting in a blood or plasma sample from an individual, the system comprising a test microchip and a reader, the test microchip comprising:
Dependencies are inferred from the claim text.